ORRIN HANSEN: Open Payments
NPI 1104916543 · AMERICAN FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 27 payments from 12 companies in 2025. Trend: 2023 $275 · 2024 $215 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $272 |
| Novo Nordisk Inc | 3 | $57 |
| Edwards Lifesciences Corporation | 1 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Corcept Therapeutics | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| HARMONY BIOSCIENCES LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $24 |
Products named: QULIPTA, VRAYLAR, Wegovy, UBRELVY, SAPIEN 3 Ultra RESILIA, SYNTHROID, JOURNAVX, CAPVAXIVE.
Industry payments across UT — which companies pay providers there.
